Rx | The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants

COMPOUNDING PHARMACY: Disadvantages

Posted on November 23, 2025 by Dr. David Edward Marcinko MBA MEd CMP™

By Dr. David Edward Marcinko MBA MEd

***

***

⚠️ Cons of Compounding Pharmacies

1. Quality and Safety Concerns

Medications are not FDA-approved, meaning they don’t go through the same rigorous testing as commercial drugs.
Risk of contamination or incorrect formulation if strict standards aren’t followed.
Potency can vary between batches, leading to inconsistent therapeutic effects.

2. Limited Regulation

Oversight is less stringent compared to mass-produced pharmaceuticals.
Standards may differ depending on the state or the specific pharmacy.
Patients may not always know whether their compounding pharmacy meets high-quality benchmarks.

3. Insurance and Cost Issues

Compounded medications are often not covered by insurance.
They can be more expensive due to customization and small-scale production.

4. Availability and Accessibility

Not all pharmacies offer compounding services.
Patients may need to travel farther or wait longer to receive their medication.

***

5. Evidence and Efficacy

Limited clinical trials or scientific evidence supporting compounded formulations.
Effectiveness may rely heavily on anecdotal reports rather than standardized studies.

6. Risk of Errors

Human error in measuring, mixing, or labeling can lead to incorrect dosages.
Lack of standardized packaging may increase confusion for patients.

👉 In short: while compounding pharmacies can provide personalized solutions, the downsides include less regulation, higher costs, safety risks, and limited evidence of efficacy compared to FDA-approved medications.

COMMENTS APPRECIATED

EDUCATION: Books

SPEAKING: Dr. Marcinko will be speaking and lecturing, signing and opining, teaching and preaching, storming and performing at many locations throughout the USA this year! His tour of witty and serious pontifications may be scheduled on a planned or ad-hoc basis; for public or private meetings and gatherings; formally, informally, or over lunch or dinner. All medical societies, financial advisory firms or Broker-Dealers are encouraged to submit an RFP for speaking engagements: CONTACT: Ann Miller RN MHA at MarcinkoAdvisors@outlook.com -OR- http://www.MarcinkoAssociates.com

Like, Subscribe and Refer

***

Filed under: "Doctors Only", Drugs and Pharma, Ethics, Health Law & Policy, iMBA, Inc., Marcinko Associates | Tagged: compounding pharmacy, costs, david marcinko, DEA, Drugs, FDA, health, healthcare, medicine, pharmacist, prescriptions, quality, Rx, safety, Technology | Leave a comment »

Safe Disposal: National Prescription Drug Take Back Day

Posted on October 25, 2025 by Dr. David Edward Marcinko MBA MEd CMP™

PODCAST: National Prescription Drug Take Back Day

October 25, 2025

By Dr. David Edward Marcinko MBA MEd

***

The National Prescription Drug Take Back Day aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for abuse of medications.

Prescription Pill Bottles

PODCAST: https://www.bing.com/videos/search?q=dea+take+back+day&&view=detail&mid=0D5B986D9C5FD79B077B0D5B986D9C5FD79B077B&&FORM=VRDGAR

MORE DEA: https://takebackday.dea.gov/

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

Ambulance DEM

***

Filed under: "Doctors Only", Drugs and Pharma, Ethics, Experts Invited, LifeStyle, Touring with Marcinko, Videos | Tagged: "Illegal" Drugs, david marcinko, DEA, drug take back day, Marcinko, National Prescription Drug Take-Back Day, october, Rx | 1 Comment »

Understanding Pre-Payment Health Plans

Posted on October 2, 2025 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

SPONSOR: http://www.CertifiedMedicalPlanner.org

***

***

Classic: A pre-payment plan refers to health insurance plans that provide medical or hospital benefits in service rather than dollars, such as the plans offered by various Health Maintenance Organizations. A method providing in advance for the cost of predetermined benefits for a population group, through regular periodic payments in the form of premiums, dues, or contributions including those contributions that are made to a health and welfare fund by employers on behalf of their employees!

Modern: A Prepaid Group Practice Plan specifies health services are rendered by participating physicians to an enrolled group of persons, with a fixed periodic payment made in advance by (or on behalf of) each person or family. If a health insurance carrier is involved, a contract to pay in advance for the full range of health services to which the insured is entitled under the terms of the health insurance contract.

Examples:

Pre-Paid Hospital Service Plan: The common name for a health maintenance organization (HMO), a plan that provides comprehensive health care to its members, who pay a flat annual fee for services.
Pre-Paid Premium: An insurance or other premium payment paid prior to the due date. In insurance, payment by the insured of future premiums, through paying the present (discounted) value of the future premiums or having interest paid on the deposit.
Pre-Paid Prescription Plan: A drug reimbursement plan that is paid in advance.

COMMENTS APPRECIATED

Refer and Like

***

Filed under: "Ask-an-Advisor", CMP Program, Drugs and Pharma, Financial Planning, Glossary Terms, Health Economics, Health Insurance, Healthcare Finance | Tagged: CMP, deductibles, drug, Health Insurance, HMO, hospital plan, pho, PPO, premiums, Prepaid Group Practice Plan, prescription plan, Rx | Leave a comment »

Physician V. Doctor V. Provider V. Prescriber V. Medical Others

Posted on May 22, 2025 by Dr. David Edward Marcinko MBA MEd CMP™

HEALTHCARE DEFINITIONS

By Staff Reporters

SPONSOR: http://www.CertifiedMedicalPlanner.org

***

***

When you visit health clinic or hospital for a medical appointment, you’ll be seen by a doctor, healthcare provider and/or medical prescriber. But what do these words really mean?

***

Doctors / Physicians

Doctor of Medicine (MD), Doctor of Podiatric Medicine (DPM), Doctor of Osteopathy (DO, or Doctor of Dental Surgery (DDS/DMD). Doctors, also known as physicians, have extensive prescription privileges across various specialties. They can diagnose medical conditions, prescribe medication, and oversee the overall management of patient care. Doctors include general practitioners, specialists such as cardiologists or dermatologists, and surgeons. Their prescription authority encompasses a wide range of medications to address acute and chronic health conditions, ranging from antibiotics to specialized treatments for complex diseases.

MORE: https://medicalexecutivepost.com/2023/06/17/the-md-versus-do-degree/

***

Medical Providers

A medical provider is a general term that encompasses a wide range of education levels, skill-sets, and specializations. A provider could be a Physician Assistant (PA), Nurse Practitioner (NP), Clinical Nurse Specialist (CNS), Doctor of Medicine (MD), Doctor of Podiatric Medicine (DPM), Dentist (DDSDMD) or Doctor of Osteopathy (DO).

***

Medical Drug Prescribers

Generally, psychologists and therapists do not have prescription privileges. They focus on psychotherapy and counseling rather than medication management. However, some jurisdictions may grant limited prescription rights to psychologists who undergo additional training and certification. Like psychologists, therapists typically do not have prescription privileges. They focus on providing counseling and psychotherapy to address mental health issues and emotional concerns.

PHARMACISTS: https://medicalexecutivepost.com/2025/02/12/pharmd-doctor-of-pharmacy/

Psychiatrists are medical doctors (MD/DO) who specialize in the diagnosis and treatment of mental health disorders. They have full prescription privileges and can prescribe a wide range of medications to manage psychiatric conditions.

In most cases, physical therapists do not have the authority to prescribe medication. They primarily focus on rehabilitation and physical interventions to improve mobility and function.

MORE: https://medicalexecutivepost.com/2025/02/23/doctorate-physical-therapy/

Nurse practitioners are advanced practice nurses with the authority to diagnose, treat, and prescribe medication independently in many states and countries. They undergo extensive education and training, which allows them to provide a wide range of healthcare services, including medication management.

Similar to nurse practitioners, psychiatric nurse practitioners have the authority to prescribe medication for mental health conditions. They specialize in psychiatric and mental health care, offering comprehensive treatment that may include medication management.

Chiropractors primarily focus on diagnosing and treating musculoskeletal disorders through manual adjustments and therapies. They do not have surgical or prescription privileges in most jurisdictions.

Optometrists are trained to diagnose and treat vision problems, including prescribing corrective lenses and medications for certain eye conditions such as infections or inflammation.

Registered nurses typically do not have prescription privileges. They work under the direction of physicians and nurse practitioners, assisting with patient care but not prescribing medication themselves.

Dentists have limited prescription privileges related to dental care, such as antibiotics or pain medications for dental procedures. However, they do not have the authority to prescribe general medications outside of their scope of practice.

Nutritionists typically do not have prescription privileges. They specialize in providing dietary advice and counseling to promote health and well-being through nutrition but do not prescribe medication.

Depending on their scope of practice and legal regulations in their jurisdiction, nurse midwives may have limited prescription privileges for certain medications related to prenatal care, childbirth, and postpartum care.

MORE: http://www.HealthDictionarySeries.org

COMMENTS APPRECIATED

Like and Refer

***

Filed under: Ask a Doctor, Career Development, Drugs and Pharma, Health Economics, Health Law & Policy, Healthcare Finance | Tagged: DC, DDS, dentist, dictionary, DMD, DO, Drugs, health, health dictionary, healthcare, LPN, MD, medicine, midwife, news, NP, nurse, nursing, nutritionists, OD, osteopthy, PA, PBMs, pharmacists, pmb, podiatry, providers, RN, Rx, surgery, Technology, therapist | Leave a comment »

The Missing Piece in America’s Health Care Debate

Posted on March 23, 2025 by Dr. David Edward Marcinko MBA MEd CMP™

By Rick Kahler CFP™

http://www.KahlerFinancial.com

***

The recent horrifying murder of UnitedHealthcare Group CEO Brian Thompson has called attention to the anger many Americans feel about our health care system. This tragedy has thrust the very real issue of health care costs back into the headlines.

One article on the topic, from Ken Alltucker for USA Today, offered seven reasons why Americans pay so much for health care with such poor results. When I saw the headline, I thought, “Finally, someone’s going to bring up the elephant in the room: taxes.”

The seven reasons included bloated administrative costs, lack of price transparency, overpaid specialists, higher prescription drug prices, and more. But I didn’t see a word about how, compared to other developed nations with “cheaper” health care, Americans pay far lower taxes. That omission feels like leaving a critical piece of the puzzle off the table.

***

In reality, countries with universal health care are not pulling off some magic trick of efficiency. They are simply collecting the money differently—through significantly higher taxes. Americans, on the other hand, pay for health care more directly, through out-of-pocket costs and insurance premiums.

In a column last year, I did the math. Americans spend about 17.8% of GDP on health care, plus 27.7% of GDP in taxes. That’s a total of 45.5%. Now compare that to twelve European countries with universal health care. They spend a median of 11.5% of GDP on health care and collect 41.9% of GDP in taxes. Total? 53.4%. In other words, Americans are spending 7.9% less overall on healthcare and taxes combined.

The saving isn’t what it appears, though. A fair comparison of healthcare costs and taxes needs to account for the fact that universal healthcare systems cover 100% of their populations, while the U.S. system currently leaves about 8% uninsured. If you factor in the cost of covering our uninsured residents, the U.S. likely spends a comparable percentage of income on healthcare as European countries with universal systems.

***

***

Our system is far from perfect. As the USA Today article points out, administrative costs are bloated. Harvard’s David Cutler estimates up to 25% of our health spending goes toward paperwork, phone calls, and processing. Price transparency is practically nonexistent. The cost of a diagnostic test might vary from $300 to $3,000 depending on where you go. We pay much more for prescription drugs and many procedures than those same treatments cost in other developed nations. Another issue is the fee-for-service model that rewards doctors for ordering more tests and procedures, whether or not patients get better.

We can do better. Innovations like value-based care, where providers are paid for outcomes rather than procedures, could help shift the system toward real results. Greater price transparency would empower patients to make informed choices and force providers to compete. And addressing administrative inefficiencies could save billions.

Yet fixing the system requires being honest about trade-offs. If we want universal health care at European price rates, we need to accept European tax rates. That’s the part of the conversation that often gets left out. It’s easy to be angry at hospitals, insurance companies, and drug manufacturers—and yes, they all have plenty to answer for. But we also need to face the reality that we’ve chosen a system that prioritizes lower taxes over centralized health care.

Anger may have put the flaws in our health care system in the spotlight. Finding genuine solutions will require moving beyond expressions of anger and frustration. It will demand thoughtful discussions about what kind of health care system, as individuals and as a nation, that we want and how we are willing to fund it.

EDUCATION: Books

COMMENTS APPRECIATED

Refer and Subscribe

***

Filed under: "Ask-an-Advisor", Drugs and Pharma, Ethics, Experts Invited, Health Insurance, Health Law & Policy, LifeStyle, Taxation | Tagged: books, Brian Thompson, CFP, David Cutler, Drugs, GDP, healthcare debate, history, kahler, Ken Alltucker, philosophy, rick kahler, Rx, tax, UnitedHealthcare, USA Today, value based care, VBC | Leave a comment »

DRUG: Scheduling & Classifications with Examples

Posted on March 12, 2025 by Dr. David Edward Marcinko MBA MEd CMP™

Drugs: (List of Schedule I-V Controlled Drugs)

By Staff Reporters

***

***

Any discussion on narcotics, prescription drugs, or other controlled substances is usually peppered with the word schedule. One substance may be Schedule I, while another is Schedule II, III, IV, or V.

Drugs, substances, and certain chemicals used to make drugs are classified into five (5) distinct categories or schedules depending upon the drug’s acceptable medical use and the drug’s abuse or dependency potential. The abuse rate is a determinate factor in the scheduling of the drug; for example, Schedule I drugs have a high potential for abuse and the potential to create severe psychological and/or physical dependence. As the drug schedule changes — Schedule II, Schedule III, etc., so does the abuse potential — Schedule V drugs represents the least potential for abuse.

A Listing of drugs and their schedule are located at Controlled Substance Act (CSA) Scheduling or CSA Scheduling by Alphabetical Order. These lists describes the basic or parent chemical and do not necessarily describe the salts, isomers and salts of isomers, esters, ethers and derivatives which may also be classified as controlled substances. These lists are intended as general references and are not comprehensive listings of all controlled substances.

Please note that a substance need not be listed as a controlled substance to be treated as a Schedule I substance for criminal prosecution. A controlled substance analogue is a substance which is intended for human consumption and is structurally or pharmacologically substantially similar to or is represented as being similar to a Schedule I or Schedule II substance and is not an approved medication in the United States.

Schedule I Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.

Schedule II Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Some examples of Schedule II drugs are: combination products with less than 15 milligrams of hydrocodone per dosage unit (Vicodin), cocaine, methamphetamine, methadone, hydromorphone (Dilaudid), meperidine (Demerol), oxycodone (OxyContin), fentanyl, Dexedrine, Adderall, and Ritalin

Schedule III Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Some examples of Schedule III drugs are: products containing less than 90 milligrams of codeine per dosage unit (Tylenol with codeine), ketamine, anabolic steroids, testosterone

Schedule IV Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol

Schedule V Schedule V drugs, substances, or chemicals are defined as drugs with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes. Some examples of Schedule V drugs are: cough preparations with less than 200 milligrams of codeine or per 100 milliliters (Robitussin AC), Lomotil, Motofen, Lyrica, Parepectolin

COMMENTS APPRECIATED

Subscribe and Refer

***

Filed under: "Doctors Only", Drugs and Pharma, Glossary Terms, Health Insurance, Health Law & Policy, mental health | Tagged: controlled substances schedule, CSA, drug classifications, drug schedules, Drugs, health, PBM, PMBs, prescribed drugs, prescribed medicine, RPh, Rx, scheduled drugs | Leave a comment »

DENTISTS: Prescribing Limits

Posted on March 1, 2025 by Dr. David Edward Marcinko MBA MEd CMP™

Rx – What Dentists Can’t Do

By Staff Reporters

***

***

Dentists are limited to prescribing medications that address oral and dental health only.

For example, they cannot provide prescriptions for conditions unrelated to dentistry, such as chronic illnesses like diabetes or respiratory infections. Additionally, dentists do not prescribe medications for mental health or hormonal issues.

These limitations ensure that dental professionals focus strictly on oral health and leave more complex medical issues to general physicians or specialists. This distinction helps protect patients from receiving inappropriate or harmful treatments outside the dentist’s expertise.

COMMENTS APPRECIATED

Refer and Subscribe

***

Filed under: "Doctors Only", Drugs and Pharma, Ethics, Glossary Terms, Health Insurance, LifeStyle | Tagged: DDS, dental prescriptions, dentists, DMD, Drugs, drugs in dentristry, prescriptions, Rx, RXs | Leave a comment »

DAILY UPDATE: GoodRx as Stocks End Flat

Posted on November 21, 2024 by Dr. David Edward Marcinko MBA MEd CMP™

MEDICAL EXECUTIVE-POST – TODAY’S NEWSLETTER BRIEFING

***

Essays, Opinions and Curated News in Health Economics, Investing, Business, Management and Financial Planning for Physician Entrepreneurs and their Savvy Advisors and Consultants

“Serving Almost One Million Doctors, Financial Advisors and Medical Management Consultants Daily“

A Partner of the Institute of Medical Business Advisors , Inc.

http://www.MedicalBusinessAdvisors.com

SPONSORED BY: Marcinko & Associates, Inc.

***

http://www.MarcinkoAssociates.com

EDUCATIONAL TEXTBOOKS: https://tinyurl.com/4zdxuuwf

***

Daily Update Provided By Staff Reporters Since 2007.
How May We Serve You?

REFER A COLLEAGUE: MarcinkoAdvisors@msn.com

SPONSORSHIPS AVAILABLE: https://medicalexecutivepost.com/sponsors/

ADVERTISE ON THE ME-P: https://tinyurl.com/ytb5955z

Your Referral Count -0-

It’s not all good news for GoodRx.

CITE: https://www.r2library.com/Resource

STOCKS UP

Williams-Sonoma soared 27.50% to a record high after the home goods store beat top and bottom line earnings expectations. Its operating profit margin jumped to 17.8% from 17% last year, and the company said its board greenlit a $1 billion stock buyback plan.

Wix jumped 14.31% on a solid beat for its third quarter. Profit for the software firm reached $0.46 per share, compared to the $0.12 per share it reported last year.
Lemonade rose 16.04% after Morgan Stanley upgraded the insurance company from “underweight” to “equal-weight.” At its investor day, Lemonade unveiled a plan to juice its premiums from $1 billion to $10 billion over the next several years.

STOCKS DOWN

Ford said it was cutting 4,000 jobs in Europe, about 14% of its workforce on the continent, citing weak demand for EVs and competition from Chinese cars. Shares fell 2.90%.
Qualcomm dropped 6.34% after its first Investor Day in three years disappointed. On Tuesday, the chipmaker revealed its big plans to expand from its bread-and-butter smartphone business into making chips for cars and PCs.
Elf sank 2.23% after short seller Carson Block, the founder of Muddy Waters Research, accused the beauty company of inflating revenue.

CITE: https://tinyurl.com/2h47urt5

Here’s where the major benchmarks ended:

The S&P 500^® index (SPX) stayed mostly flat, up 0.13 points (0.0%) to 5,917.11; the Dow Jones Industrial Average^® ($DJI) rose 139.53 points (0.32%) to 43,408.47; and the NASDAQ Composite^® ($COMP) fell 21.32 points (0.11%) to 18,966.14.
The 10-year Treasury note yield added four basis points to 4.41%.
The CBOE Volatility Index^® (VIX) climbed to 17.26, near recent highs.

CITE: https://tinyurl.com/tj8smmes

Visualize: How private equity tangled banks in a web of debt, from the Financial Times.

COMMENTS APPRECIATED

PLEASE SUBSCRIBE: MarcinkoAdvisors@msn.com

Thank You

***

EDUCATIONAL TEXTBOOKS: https://tinyurl.com/4zdxuuwf

***

Filed under: "Ask-an-Advisor", Drugs and Pharma, Ethics, Financial Planning, Funding Basics, Information Technology, Investing, Marcinko Associates, Recommended Books, Sponsors | Tagged: DJIA, DOW, finance, GoodRx, Investing, Marcinko, NASA, NASDAQ, personal-finance, Rx, S&P 500, stock market, stocks, stocks flat, textbooks, TNX, VIX, WSJ | Leave a comment »

DAILY UPDATE: Kroger Selling Pharma Business as Nvidia and Stock Markets Rise

Posted on March 21, 2024 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

CHERRY BLOSSOM FESTIVAL, DC.

***

***

KROGER, the supermarket chain said it expects to close the sale of its specialty pharmacy business during the second half of 2024. Kroger said it is planning to sell its speciality pharmacy business to pharmacy benefit manager CarelonRx, a subsidiary of Elevance Health, the company just reported.

CITE: https://www.r2library.com/Resource

***

Nvidia continues its bid for world domination with the announcement of its new B200 “Blackwell” chip. The Blackwell is 2.5 times more powerful than the “Hopper” chip which helped it become a $2 trillion company. (Bloomberg)

Here’s where the major benchmarks ended:

The S&P 500 index added 46.11 points (0.9%) to 5,224.62; the Dow Jones Industrial Average gained 401.37 points (1%) to 39,512.13; the NASDAQ Composite rose 202.62 points (1.3%) to 16,369.41.
The 10-year Treasury note yield slid two basis points to 4.27%.
The CBOE Volatility Index^®(VIX) fell 0.77 to 13.06.

Health care was the biggest loser among the S&P 500 sectors. Energy was also lower after crude oil prices sank on the heels of weekly inventory data. Brent Crude Oil (/BZ) futures, the global benchmark, dropped 1.6% on the heels of five days of gains.

COMMENTS APPRECIATED

Thank You

***

Filed under: "Ask-an-Advisor", Breaking News, Drugs and Pharma, Ethics, Experts Invited, Financial Planning, Health Economics, Health Insurance, Healthcare Finance, Information Technology, Investing | Tagged: Blackwell chip, brent, CarelonRx, CBOE, crude oil, DJIA, DOW, Drugs, Elevance Health, Hopper chip, Kroger, medical debt, NASDAQ, Nvidia, pharma, prescriptions, Rx, S&P 500, specialty pharma, VIX | Leave a comment »

PODCAST: Doctors Subconsciously Influenced By Pharmaceutical Companies?

Posted on January 26, 2024 by Dr. David Edward Marcinko MBA MEd CMP™

Dr. Eric Bricker MD

***

COMMENTS APPRECIATED

Thank You

***

Filed under: "Doctors Only", Career Development, Drugs and Pharma, Experts Invited, Industry Indignation Index, Op-Editorials, Videos | Tagged: Drugs, Eric Bricker, pharma, pharmaceutical companies, pharmaceuticals, prescriptions, Rx | Leave a comment »

UBER Health: Rx Drug Delivery Service

Posted on September 28, 2023 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

“Uber Health is foraying deeper into healthcare with a new feature that allows providers to order prescriptions to be dropped off at patients homes same-day. The same-day prescription delivery is meant to help patients adhere to a medication schedule.”

According to Rebecca Pifer of HealthCareDive:

Uber Health is foraying deeper into healthcare with a new feature that allows providers to order prescriptions to be dropped off at patients homes same-day.
The same-day prescription delivery is meant to help patients adhere to a medication schedule. The service is made possible through an integration of Uber Health’s dashboard with ScriptDrop, a tech platform connecting patients and pharmacies with couriers nationwide.
The company also said it expects to soon launch delivery of healthy food and over-the-counter medicine for patients, including Medicare Advantage and Medicaid beneficiaries.
CITE: https://www.r2library.com/Resource/Title/0826102549

***

COMMENTS APPRECIATED

Thank You

***

Filed under: Alternative Investments, Career Development, Drugs and Pharma, Ethics, Health Economics, Health Insurance, Information Technology, LifeStyle, Managed Care | Tagged: drug delivery, Drugs, Medicare Advantage, prescriptions, Rebecca Pifer, Rx, Rx delivery, ScriptDrop, Uber, Uber Health | Leave a comment »

DEA Temporarily Extends Tele-Health Prescribing Flexibility

Posted on May 7, 2023 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

***

Tele-Health medical providers are cheering the Drug Enforcement Agency (DEA) move to temporarily extend virtual prescribing flexibility.

The DEA is looking to buy some time to consider whether it should require patients to see doctors face-to-face to get prescriptions for controlled drugs or continue to allow Tele-Health prescriptions. The agency received a record 38,000 public comments on its proposed rule.

Source: Heather Landi, Fierce Healthcare [5/3/23]

***
COMMENTS APPRECIATED

Thank You

***

Filed under: "Doctors Only", Career Development, Drugs and Pharma, Experts Invited, Health Insurance, Health Law & Policy, Information Technology | Tagged: DEA, Drugs, e-RX, Fierce Healthcare, Health Landi, prescription drugs, prescriptions, Rx, Tele-Health, tele-medicine | Leave a comment »

SCOTUS: Ruled on Opioid Prescriptions

Posted on September 20, 2022 by Dr. David Edward Marcinko MBA MEd CMP™

By Jules Murtha

***

***

Here’s What Doctors Need to Know

The Supreme Court of the United States (SCOTUS) has ruled that doctors must show intent to mis-prescribe opioids in order to face criminal charges.

Despite the drop in opioid prescriptions in recent years, opioid overdoses and deaths are on the rise, largely because of street drugs.
The CDC’s position is that physicians can better serve patients by focusing on when to initiate and continue opioid treatment, what type and dosage of opioid to use, and how to address risk of drug abuse when prescribing opioids.

Source: Jules Murtha, MD Linx [8/26/22]

***

COMMENTS APPRECIATED

Thank You

***

DHITS: https://www.amazon.com/Dictionary-Health-Information-Technology-Security/dp/0826149952/ref=sr_1_5?ie=UTF8&s=books&qid=1254413315&sr=1-5

***

Filed under: "Doctors Only", Drugs and Pharma, Experts Invited, Practice Management | Tagged: Jules Murtha, OPIOID CRISIS?, prescription drugs, Rx, SCOTUS: Ruled on Opioid Prescriptions | Leave a comment »

PODCAST: The Financial Cost of Medication Non-Adherence

Posted on May 25, 2022 by Dr. David Edward Marcinko MBA MEd CMP™

Cost of Medication Non-Adherence: 33- 69% of Hospitalizations

By Eric Bricker MD

***

COMMENTS APPRECIATED

Thank You

***

CITE: https://www.r2library.com/Resource/Title/082610254

***

****

Filed under: "Doctors Only", Career Development, Drugs and Pharma, Experts Invited, Glossary Terms, Health Economics, Health Insurance, Videos | Tagged: drug costs, Drugs, Eric Bricker MD, Financial Cost of Medication Non-Adherence, Medication Non-Adherence, patient drug non-adherence, prescriptions, Rx | Leave a comment »

56% of Patients Attempted to Stretch Out a Prescription

Posted on February 22, 2022 by Dr. David Edward Marcinko MBA MEd CMP™

***

By Staff Reporters

***

***

56% of Patients Attempted to Stretch Out a Prescription According tot a Recent CoverMyMeds Survey of 1,000 patients. It found:

• 79% of patients said they’ve gone to the pharmacy only to discover a prescription cost more than they expected.
• When faced with an affordability challenge, 56% of patients attempted to stretch out a prescription.
• When faced with an affordability challenge, 52% of patients skipped bills or other essential items to afford medications.
• When faced with an affordability challenge, 51% of patients sacrificed medications to pay bills and other essentials.

Source: CoverMyMeds, “2022 Medication Access Data Guide,” February 2022

***

CITE: https://www.r2library.com/Resource/Title/0826102549

Rx Podcast: https://medicalexecutivepost.com/2022/02/20/podcast-how-to-write-a-medical-prescription-rx/

COMMENTS APPRECIATED

Thank You

Subscribe to the Medical Executive-Post

***

Filed under: Drugs and Pharma, Health Economics, Health Insurance | Tagged: CoverMyMeds, MCOL, medical bills, medication bills, medications, pay medical bills, pharmacy, prescribed drugs, prescriptions, Rx | Leave a comment »

PODCAST: How to Write a Medical Prescription [Rx]

Posted on February 20, 2022 by Dr. David Edward Marcinko MBA MEd CMP™

There are 7 Parts to a Physican’s Drug Prescription

By Eric Bricker MD

***

CITE: https://www.r2library.com/Resource/Title/082610254

***

COMMENTS APPRECIATED

Thank You

Subscribe to the Medical Executive-Post

***

Filed under: Drugs and Pharma, Experts Invited, Quality Initiatives | Tagged: DEA, doctor's Rx, drug license number, drug prescriptions, Eric Bricker MD, How to Write a Medical Prescription, prescriptions, Rx | 1 Comment »

PODCAST: What is a Medication Formulary?

Posted on January 13, 2022 by Dr. David Edward Marcinko MBA MEd CMP™

***

By Eric Bricker MD

***

Why Are Certain Medications Non-Formulary?

What Are Formulary Tiers and Its Rules?

Formularies Have Many Rules Associated With Them:

1) Prior Authorization – Approval Must Be Given by the Health Insurance Company/PBM Before They Agree to Pay for a Medication.

2) Step Therapy – Certain Less Expensive Generic Medications Have to Be ‘Tried’ First and Fail Before a Doctor Can Prescribe a More Expensive Brand-Name Medication.

3) Mandatory Generics – If a Brand Name Medication Has A Direct Generic Equivalent, Then the Insurance May Only Agree to Pay for the Generic and Not the Brand.

4) Mandatory Mail Order – Certain Chronic Medications That Are Filled for 90 Day Supplies Must Be Filled via Mail Order and Not at the Retail Pharmacy.

***

PODCAST: https://www.youtube.com/watch?v=kEjDBp9HdBk

***

COMMENTS APPRECIATED.

Subscribe to the Medical Executive-Post

Thank You

HEALTH ECONOMICS CITE: https://www.r2library.com/Resource/Title/0826102549

***

***

Filed under: "Advisors Only", Drugs and Pharma, Experts Invited, Videos | Tagged: brand name drugs, drug formularies, Drugs, Eric Bricker MD, Formulary, generic drugs, medications, PBM, Prior Authorization, Rx, step therapy | Leave a comment »

PODCASTS: How Prescription [Rx] Coverage Works

Posted on December 19, 2021 by Dr. David Edward Marcinko MBA MEd CMP™

Formulary Tiers, PBM, Rebates, Spread-Pricing Explained

By Dr. Eric Bricker MD

***

***

CITE: https://www.r2library.com/Resource/Title/082610254

***

***
YOUR COMMENTS ARE APPRECIATED.

Thank You

***

Filed under: Drugs and Pharma, Experts Invited, Funding Basics, Glossary Terms, Health Insurance, Healthcare Finance, Practice Management, Videos | Tagged: Anthem, Caremark, Cigna, CVs, DEA, drug rebates, drug tiers, Drugs, Eric Bricker MD, Express Scripts, Formulary, Health Insurance, medications, Optum, PBM, PBMs, pharmacy, prescription coverage, Rx, spread drug pricing, UHC, United Health Care | Leave a comment »

PODCAST: Using “GoodRx” to Check Prescription Prices

Posted on August 18, 2021 by Dr. David Edward Marcinko MBA MEd CMP™

BY ERIC BRICKER MD

YOUR THOUGHTS AND COMMENTS ARE APPRECIATED.

Thank You

CITE: https://www.r2library.com/Resource/Title/0826102549

***

Filed under: Drugs and Pharma, Experts Invited, Videos | Tagged: Drugs, Eric Bricker MD, GoodRx, PBM, prescriptions, Rx | Leave a comment »

Our Rx Drugged Culture

Posted on February 2, 2012 by Dr. David Edward Marcinko MBA MEd CMP™

America’s Most Prescribed Psychiatric Drugs

Conclusion

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

DICTIONARIES: http://www.springerpub.com/Search/marcinko
PHYSICIANS: www.MedicalBusinessAdvisors.com
PRACTICES: www.BusinessofMedicalPractice.com
HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
CLINICS: http://www.crcpress.com/product/isbn/9781439879900
ADVISORS: www.CertifiedMedicalPlanner.org
BLOG: www.MedicalExecutivePost.com
FINANCE: Financial Planning for Physicians and Advisors
INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors

Filed under: Drugs and Pharma | Tagged: America's Most Prescribed Psychiatric Drugs, ativan, cymbalta, Drugs, prozac, Psychiatric Drugs, Rx, valium, xanax, zoloft | 3 Comments »

Internet Drug Rx Abuse

Posted on July 30, 2008 by Dr. David Edward Marcinko MBA MEd CMP™

NCASA Study

Staff Reporters

A large majority of 365 Internet sites that advertise or sell controlled medications by mail are offering to supply the drugs without a proper prescription, while the online trade is stoking the rising abuse of addictive and dangerous prescription drugs, according to a National Center on Addiction and Substance Abuse [NCASA] at Columbia University.

The Study

Federal and state efforts to crack down on Internet sales appear to have reduced the number of sites offering such drugs, from 581 last year, according to a New York Times report on July 9, 2008. Drugs offered online include generic versions of opiates like OxyContin, methadone and Vicodin, which are legitimately prescribed as painkillers; benzodiazepines like Xanax and Valium, which are prescribed for anxiety; and stimulants like Ritalin.

DEA Assessment

The Drug Enforcement Administration [DEA] found that 85 percent of all Internet prescription sales involved controlled drugs, compared with just 11 percent of those filled through regular pharmacies, suggesting that online sales often are destined for misuse.

Conclusion

Do you think the current eRx initiatives will drive or reduce this phenomenon; please opine and comment?

Related Information Sources:

Practice Management: http://www.springerpub.com/prod.aspx?prod_id=23759

Physician Financial Planning: http://www.jbpub.com/catalog/0763745790

Medical Risk Management: http://www.jbpub.com/catalog/9780763733421

Healthcare Organizations: www.HealthcareFinancials.com

Health Administration Terms: www.HealthDictionarySeries.com

Physician Advisors: www.CertifiedMedicalPlanner.com

Subscribe Now: Did you like this Executive-Post, or find it helpful, interesting and informative? Want to get the latest E-Ps delivered to your email box each morning? Just subscribe using the link below. You can unsubscribe at any time. Security is assured.

Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos

Copyright 2008 iMBA Inc: All rights reserved, USA, unless otherwise noted. Use is restricted to Executive-Post subscribers only. No redistribution is allowed. To avoid violation of iMBA Inc copyright restrictions and redistribution policy, please register for your own free Executive-Post membership. Detailed information and registration links are available at:

Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos

Referrals: Thank you in advance for your electronic referrals to the Executive-Post.

Filed under: Breaking News, Drugs and Pharma, Health Law & Policy, Information Technology, Surveys and Voting | Tagged: internet, Rx | 3 Comments »

Subscribe MEDICAL EXECUTIVE-POST?

Member Statistics

ME-P Information & Content Channels

Ann Miller RN MHA [Managing Editor]

CERTIFIED MEDICAL PLANNER® program

Most Recent ME-Ps

PodiatryPrep.org

ME-P Free Advertising Consultation

Medical & Surgical e-Consent Forms

iMBA Inc., OFFICES

ME-P Publishing

SEEKING INDUSTRY INFO PARTNERS?

Reader Comments, Quips, Opinions, News & Updates

Start-Up Advice for Businesses, DRs and Entrepreneurs

Up-Trending ME-Ps

Capitalism and Free Enterprise Advocacy

OIG Fraud Warnings

⚠️ Cons of Compounding Pharmacies

1. Quality and Safety Concerns

2. Limited Regulation

3. Insurance and Cost Issues

4. Availability and Accessibility

5. Evidence and Efficacy

6. Risk of Errors

Share this:

October 25, 2025

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

STOCKS UP

STOCKS DOWN

CITE: https://tinyurl.com/2h47urt5

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Calendar

Advertising Info:

Book Offerings:

Dictionary Offerings:

Dr. David Marcinko [Publication List]

Education Online:

Health Dictionary Series Wiki Project

Lower Extremity Medicine & Surgery

Pending NIHCM Grant Applications:

Practice Lists:

Professor Marcinko

Related Blogs:

Speaker's Bureau:

Thought-Leaders:

White Papers: